Call for Nominations for ICIS Prestigious Awards in Interferon and Cytokine Research

International Cytokine & Interferon Society

Milstein Award

Recognition by the International Cytokine & Interferon Society for outstanding achievements furthering research on interferon, cytokines and chemokines.

The 2016 Seymour & Vivian Milstein Award went to 3 premier scientists who've translated basic research findings into clinical benefit for thousands of patients, Carl Nathan, John O’Shea, & Jan Vilcek.”

— Tadatsugu Taniguchi

ORADELL, NEW JERSEY, UNITED STATES, April 12, 2017 /EINPresswire.com/ — The Seymour and Vivian Milstein Award for Excellence in Interferon and Cytokine Research

This award represents the pinnacle of scientific achievement in interferon and cytokine research. It is bestowed upon a leading biomedical research scientist, who may not be an ICIS member, who has made outstanding contributions to interferon and cytokine research, either in a basic or applied field. Many laureates have made seminal advancements that have enabled the successful treatment of disease or have the potential to lead to significant health benefits.

Award: $10,000. ICIS Crystal. Travel (flights and hotel expenses) reimbursement to attend the Annual Meeting and meeting registration for Cytokines 2017 waived.

Sidney & Joan Pestka Graduate and Post-Graduate Awards in Interferon & Cytokine Research

These awards are targeted to graduate students and post-doctoral fellows who have begun to make an impact in interferon and cytokine research.

Award: The award includes a $3500 cash award, $1500 travel grant (if they attend the annual meeting), a $2500 PBL Assay Science product credit for each awardee and a complimentary one-year ICIS membership. This is an annual award and a recipient may receive an award only once. However, an individual who receives the Graduate Award remains eligible for the Post- Graduate Award.

ICIS-BioLegend William E. Paul Award.

This Award is given to an investigator that has made significant contributions to cytokine and interferon research throughout his/her career.

Award: $2,500. ICIS crystal with the 3D structure of IL-4, the cytokine most associated with Dr. Paul’s research.

These prestigious awards are open to all those involved in Interferon & Cytokine Research.

Nominations will be accepted until 1 May 2017 for these prestigious symbols of recognition by our society for outstanding achievements furthering research on interferon, cytokines and chemokines.

Please use the online form, using one form for each candidate for nomination. Candidates may be nominated for more than one award using the same form, but please use a separate form for each candidate.

Joan Oefner
International Cytokine & Interferon Society (ICIS)
1-800-947-1960
email us here


Source: EIN Presswire

Two New Board Members Join The Pacific Mesothelioma Center to Help Fight Mesothelioma

Kellie Sutherland

Joseph Garland

The Pacific Mesothelioma Center has announced the appointment of Kellie Sutherland and Joseph Garland to its board of directors.

LOS ANGELES, CA, U.S.A, April 12, 2017 /EINPresswire.com/ — The Pacific Heart, Lung & Blood Institute (PHLBI), a division of which is the Pacific Mesothelioma Center (PMC), has announced the appointment of Kellie Sutherland and Joseph Garland to its board of directors.

Kellie, an engineer who has worked with Northrop-Grumman for the past nine years, received her Masters of Arts in Organization Management and a Bachelors of Science in Business Management at the University of Phoenix. Kellie has volunteered for the Institute for the last 2 years, arranging health fairs and lunch meetings to raise awareness for mesothelioma and has headed up a Northrop- Grumman walk team each year. She is appointed to the role of Secretary of the Board.

“I was impressed with this organization from the very beginning and that is why I have carried a banner for them. Now I am more than excited about being part of this board at this important time for the Institute as they make big strides in their mesenchymal stem cell research” said Kellie. I am honored to be working with such an amazing and dedicated team”.

The second appointment to the board is Joseph Garland, who is the Managing Partner and CEO at Centennial Harvest Group. Joseph has over 20 years of experience in healthcare. He is board certified in Healthcare management and holds the distinction of Fellow, American College of Healthcare Executives.

He received an MBA in Health Services Management at Keller Graduate School of Management and a Masters in Health Administration from USC. Joseph is committed to advancing public health while improving Healthcare organization's outcomes and sustainability.

“What interests me most about committing my time and energy to PHLBI is their mission and commitment to health advancements through research and innovation, and as such I feel the PMC’s mission is a good fit for me” Joseph stated.

“We are delighted with the appointment of both these dedicated and passionate individuals to the board of directors at a crucial time as we move forward in our fight to defeat mesothelioma”, said Rhonda Ozanian, chair of the board of directors at the PMC.

About The Pacific Mesothelioma Center:
The Pacific Heart, Lung & Blood Institute (PHLBI), a 501(c)(3) is a non-profit medical research institute established in 2002. One of the divisions, The Pacific Mesothelioma Center (PMC) is focused on the treatment and prevention of malignant pleural mesothelioma (MPM). The exploration of innovative ideas forms the foundation of PMC’s unique research program and provides the promise of future treatment breakthroughs. PMC is dedicated to educating the public on asbestos-related diseases and informing them of their best treatment options. PMC also connects newly diagnosed patients with patients that have been through treatment and provides assistance and emotional support.

Clare Cameron
The Pacific Mesothelioma Center
310-478-4678
email us here


Source: EIN Presswire

Caregiving Advocate Cheryl Ginnings to be Featured on CUTV News Radio

Most of the time people don’t think they’re courageous, but you are when you’re caring for someone.”

— Cheryl Ginnings

LAWTON, OKLAHOMA, UNITED STATES, April 12, 2017 /EINPresswire.com/ — Caring for a loved one in need is a truly thankless job often done purely out of a sense of love and responsibility. According to the Center for Disease Control, more than 34 million unpaid caregivers provide care to someone age 18 and older who is ill or has a disability. Further studies estimate one in five of households are impacted by caregiving responsibilities

But who is caring for the caregivers? Anyone who has served as a caregiver can tell you that it is a profound experience, fraught with emotion, overwhelming stress and even guilt.

“Caregivers often forget to care for themselves,” says Cheryl Ginnings. “There are few if any resources available to support these individuals. The burden is so great.”

Ginnings is the author of It Takes Courage to be a Caregiver released in December and available on Amazon.

Caregivers struggle when they are thrust into the role of being responsible for others. It might be a newborn child with special needs or an aging parent with Alzheimer’s or Dementia. Who can these caregivers speak to about their new role? Where can they find support? Ginnings offers tips to care for yourself and your loved one and remain balanced.

“Most people keep it to themselves,” says Ginnings. “When they are stressed out, they need someone they can talk to, someone outside of the family. Often, all they really need is to be reassured they’re doing a good job.”

Ginnings’ experiences caring for her son with cerebral palsy and helping care for several family members inspired her to create the Courage to Overcome Program, connecting caregivers to help them understand the problems caregiving families face. Ginnings serves as a voice for those “who have no voice.”

“If you are a caregiver you already belong in my club,” says Ginnings. “You’re not alone. You’re not the only person going through this. It just feels like you are. What I try to do with my Courage to Overcome Program is to find out how they found the courage to do what they’re doing. Most of the time people don’t think they’re courageous. But you are when you’re caring for someone.”

CUTV News Radio will feature Cheryl Ginnings in an interview with Doug Llewelyn on April 14th and April 21st at 1pm EST.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Cheryl Ginnings, visit http://www.CourageToOvercome.club and http://www.cherylginnings.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Global Healthcare Linen Market 2017 Share, Trend, Segmentation and Forecast to 2022

Global Healthcare Linen market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer

PUNE, MAHARASTRA, INDIA, April 12, 2017 /EINPresswire.com/ — Summary

Global Healthcare Linen market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Aramark Medical Linen Service & Supply
Angelica Corporation
Medico Linen
Spotless
Medline Industries
Emes Textiles Pvt. Ltd
Towel & Linen (Pty) Ltd
Crothall Healthcare Inc
Synergy Health

Click here for a sample report @ https://www.wiseguyreports.com/sample-request/1153321-global-healthcare-linen-market-research-report-2017

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Healthcare Linen in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Disposable
Single Use

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Healthcare Linen for each application, including
Hospital
Clinic
Others

At any Query @ https://www.wiseguyreports.com/enquiry/1153321-global-healthcare-linen-market-research-report-2017

Table of Contents

Global Healthcare Linen Market Research Report 2017
1 Healthcare Linen Market Overview
1.1 Product Overview and Scope of Healthcare Linen
1.2 Healthcare Linen Segment by Type (Product Category)
1.2.1 Global Healthcare Linen Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Healthcare Linen Production Market Share by Type (Product Category) in 2016
1.2.3 Disposable
1.2.4 Single Use
1.3 Global Healthcare Linen Segment by Application
1.3.1 Healthcare Linen Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Healthcare Linen Market by Region (2012-2022)
1.4.1 Global Healthcare Linen Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Healthcare Linen (2012-2022)
1.5.1 Global Healthcare Linen Revenue Status and Outlook (2012-2022)
1.5.2 Global Healthcare Linen Capacity, Production Status and Outlook (2012-2022)

…..

7 Global Healthcare Linen Manufacturers Profiles/Analysis
7.1 Aramark Medical Linen Service & Supply
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Healthcare Linen Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Aramark Medical Linen Service & Supply Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Angelica Corporation
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Healthcare Linen Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Angelica Corporation Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Medico Linen
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Healthcare Linen Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Medico Linen Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Spotless
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Healthcare Linen Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Spotless Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Medline Industries
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Healthcare Linen Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Medline Industries Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Emes Textiles Pvt. Ltd
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Healthcare Linen Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Emes Textiles Pvt. Ltd Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Towel & Linen (Pty) Ltd
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Healthcare Linen Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Towel & Linen (Pty) Ltd Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Crothall Healthcare Inc
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Healthcare Linen Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Crothall Healthcare Inc Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Synergy Health
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Healthcare Linen Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Synergy Health Healthcare Linen Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview

Buy Now https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1153321

Continued….

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Global Liquid chromatography Instruments Market Key Growth Drivers, Challenges, Demand and Upcoming Trends

Liquid chromatography Instruments Market by Type (High pressure liquid chromatography, Liquid-solid chromatography), by End User – Forecast to 2027

Major key Players include AC Analytical Controls BV,Thermo Fisher Scientific, Inc,Phenomenex, Inc.,Agilent Technologies,PerkinElmer, Inc.,Shimadzu Corporation,Waters Corporation”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, April 12, 2017 /EINPresswire.com/ — Market Synopsis of Liquid chromatography Instruments
Globally the market for Liquid chromatography Instruments is increasing rapidly the main reason for this is the growth in pharmaceutical industry. The factors that influence the growth of Liquid chromatography Instruments market are the increasing development in pharmaceutical industry for understanding appropriate chemical for introducing new medicine and maintain pharmaceutical quality. The market is also growing due to usage of Liquid chromatography Instruments in industries such as Biotechnology and pharmaceuticals industries, Hospitals, research laboratories, Agriculture industries and others.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/1058

Segments
On the basis of type
• High pressure liquid chromatography (HPLC)
• Ultra high pressure liquid chromatography (UHPLC)
• Low pressure liquid chromatography (LPLC)
• Liquid-solid chromatography
• Normal phase chromatography
• Reverse phase chromatography
• Flash chromatography
• Partition chromatography
• Ion chromatography
• Size exclusion chromatography
• Affinity chromatography
• Chiral chromatography.
On the basis End Users
• Biotechnology
• pharmaceuticals industries
• Hospitals
• research laboratories
• Agriculture industries
• others.

Key Players
• AC Analytical Controls BV (Netherlands),
• Thermo Fisher Scientific, Inc. (U.S.),
• Phenomenex, Inc. (U.S.).,
• Agilent Technologies (U.S.),
• PerkinElmer, Inc. (U.S.),
• Shimadzu Corporation (Japan),
• Waters Corporation (U.S.),
• JASCO, Inc. (U.S.),
• Novasep Holding S.A.S. (France),
• Pall Corporation (U.S.),
• GL Sciences, Inc. (Japan).

"Ask for your specific company profile and country level customization on reports"

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Liquid chromatography Instruments Market Research Report – Forecast to 2027”

Study Objectives of Liquid chromatography Instruments
• To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the global Liquid chromatography Instruments market
• To provide insights about factors affecting the market growth
• To Analyze the Liquid chromatography Instruments market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia, and Rest of the World (ROW)
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segment by Type, End Users and its sub-segments.
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Request TOC, Tables, Figures and Companies mentioned @ https://www.marketresearchfuture.com/request-toc/1058

The market is divided into the following segments based on geography:
North America
• US
• Canada
• Mexico
Europe
• Germany
• France
• Italy
• U.K
• Rest of Europe
Asia– Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Brazil
• Argentina
• Egypt
• South Africa Others

Key questions answered in this report
• What will the market size be in 2027 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Related Report
Global Blood Transfusion Diagnostics Market Information by Type (Instruments, Reagents), By Application (Blood Grouping, disease Screening), By End users (Hospital, laboratories, Blood Banks, Plasma Fractionation Facilities) – Forecast to 2027.Know more about this report @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Chronic Cough Therapeutics strategies and Product Pipeline Review 2017

Chronic Cough Assessment and Therapeutics Pipeline Review H1 2017

PUNE, INDIA, April 12, 2017 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development for Chronic Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Cough and features dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/711827-chronic-cough-pipeline-review-h2-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global therapeutic landscape of Chronic Cough
– The report reviews pipeline therapeutics for Chronic Cough by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Chronic Cough therapeutics and enlists all their major and minor projects
– The report assesses Chronic Cough therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Chronic Cough

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Chronic Cough
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Chronic Cough pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Cough Overview 7
Therapeutics Development 8
Pipeline Products for Chronic Cough – Overview 8
Pipeline Products for Chronic Cough – Comparative Analysis 9
Chronic Cough – Therapeutics under Development by Companies 10
Chronic Cough – Therapeutics under Investigation by Universities/Institutes 11
Chronic Cough – Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Chronic Cough – Products under Development by Companies 14
Chronic Cough – Products under Investigation by Universities/Institutes 15
Chronic Cough – Companies Involved in Therapeutics Development 16
Afferent Pharmaceuticals, Inc. 16
AstraZeneca Plc 17
Conrig Pharma ApS 18
GlaxoSmithKline Plc 19
Glenmark Pharmaceuticals Ltd. 20
GW Pharmaceuticals Plc 21
NeRRe Therapeutics Ltd 22
Patara Pharma, Inc. 23
Pila Pharma AB 24
Chronic Cough – Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Target 26
Assessment by Mechanism of Action 28
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 33
AF-219 – Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
cromolyn sodium – Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
GRC-17536 – Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
GSK-2339345 – Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
lesogaberan – Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
NEO-5937 – Drug Profile 42
Product Description 42

Access Report @ https://www.wiseguyreports.com/reports/711827-chronic-cough-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Pancreatic Cancer Therapeutics strategies and Product Pipeline Review 2017

Pancreatic Cancer Therapeutics Development and Professional Review Analysis 2017

PUNE, INDIA, April 12, 2017 /EINPresswire.com/ — Summary
Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/854908-pancreatic-cancer-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Pancreatic Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 15, 106, 112, 1, 3, 249, 38 and 5 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 18, 7, 50 and 7 molecules, respectively.
Pancreatic Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).
– The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
Introduction 14
Pancreatic Cancer Overview 15
Therapeutics Development 16
Pancreatic Cancer – Therapeutics under Development by Companies 18
Pancreatic Cancer – Therapeutics under Investigation by Universities/Institutes 45
Pancreatic Cancer – Pipeline Products Glance 49
Pancreatic Cancer – Products under Development by Companies 53
Pancreatic Cancer – Products under Investigation by Universities/Institutes 88
Pancreatic Cancer – Companies Involved in Therapeutics Development 93
Pancreatic Cancer – Therapeutics Assessment 397
Drug Profiles 478
Pancreatic Cancer – Dormant Projects 1889
Pancreatic Cancer – Discontinued Products 1922
Pancreatic Cancer – Product Development Milestones 1929
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/854908-pancreatic-cancer-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
Wise Guy Consultants Pvt. Ltd.
+1 (339) 368 6938 (US)/+91 841 198 5042 (IND)
email us here


Source: EIN Presswire

Global Mental Health Software Market 2017 Size, Development Status, Type and Application, Segmentation, Forecast by 2022

Mental Health Software Market

WiseGuyReports.com adds “Mental Health Software Market 2017 Global Analysis, Growth,Opportunities Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, April 12, 2017 /EINPresswire.com/ — Mental Health Software Market:

Executive Summary

This report studies Mental Health Software in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Cerner Corporation
Qualifacts Systems Inc.
MindLinc
Core Solutions Inc.
NetSmart technologies Inc.
Epic Systems Corporation
Credible Behavioral Health Inc.
Nextgen Healthcare Information Systems LLC
Valant Medical Solutions Inc.
Welligent Inc.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/864888-global-mental-health-software-market-research-report-2017

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Mental Health Software in these regions, from 2011 to 2021 (forecast), like

North America
Europe
China
Japan
Korea
Taiwan

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Desktops/ laptops
Tablets/ Smartphone

Split by application, this report focuses on consumption, market share and growth rate of Mental Health Software in each application, can be divided into

Commercial
Residential

Access Report @ https://www.wiseguyreports.com/reports/864888-global-mental-health-software-market-research-report-2017

Table of Contents

Global Mental Health Software Market Research Report 2017
1 Mental Health Software Market Overview
1.1 Product Overview and Scope of Mental Health Software
1.2 Mental Health Software Segment by Type
1.2.1 Global Production Market Share of Mental Health Software by Type in 2015
1.2.2 Desktops/ laptops
1.2.3 Tablets/ Smartphone
1.3 Mental Health Software Segment by Application
1.3.1 Mental Health Software Consumption Market Share by Application in 2015
1.3.2 Commercial
1.3.3 Residential
1.3.4 Application 3
1.4 Mental Health Software Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Korea Status and Prospect (2011-2021)
1.4.6 Taiwan Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Mental Health Software (2011-2021)

2 Global Mental Health Software Market Competition by Manufacturers
2.1 Global Mental Health Software Production and Share by Manufacturers (2015 and 2016)
2.2 Global Mental Health Software Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Mental Health Software Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Mental Health Software Manufacturing Base Distribution, Sales Area and Product Type
2.5 Mental Health Software Market Competitive Situation and Trends
2.5.1 Mental Health Software Market Concentration Rate
2.5.2 Mental Health Software Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

7 Global Mental Health Software Manufacturers Profiles/Analysis
7.1 Cerner Corporation
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Mental Health Software Product Type, Application and Specification
7.1.2.1 Desktops/ laptops
7.1.2.2 Tablets/ Smartphone
7.1.3 Cerner Corporation Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Qualifacts Systems Inc.
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Mental Health Software Product Type, Application and Specification
7.2.2.1 Desktops/ laptops
7.2.2.2 Tablets/ Smartphone
7.2.3 Qualifacts Systems Inc. Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 MindLinc
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Mental Health Software Product Type, Application and Specification
7.3.2.1 Desktops/ laptops
7.3.2.2 Tablets/ Smartphone
7.3.3 MindLinc Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Core Solutions Inc.
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Mental Health Software Product Type, Application and Specification
7.4.2.1 Desktops/ laptops
7.4.2.2 Tablets/ Smartphone
7.4.3 Core Solutions Inc. Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 NetSmart technologies Inc.
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Mental Health Software Product Type, Application and Specification
7.5.2.1 Desktops/ laptops
7.5.2.2 Tablets/ Smartphone
7.5.3 NetSmart technologies Inc. Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Epic Systems Corporation
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Mental Health Software Product Type, Application and Specification
7.6.2.1 Desktops/ laptops
7.6.2.2 Tablets/ Smartphone
7.6.3 Epic Systems Corporation Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Credible Behavioral Health Inc.
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Mental Health Software Product Type, Application and Specification
7.7.2.1 Desktops/ laptops
7.7.2.2 Tablets/ Smartphone
7.7.3 Credible Behavioral Health Inc. Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Nextgen Healthcare Information Systems LLC
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Mental Health Software Product Type, Application and Specification
7.8.2.1 Desktops/ laptops
7.8.2.2 Tablets/ Smartphone
7.8.3 Nextgen Healthcare Information Systems LLC Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Valant Medical Solutions Inc.
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Mental Health Software Product Type, Application and Specification
7.9.2.1 Desktops/ laptops
7.9.2.2 Tablets/ Smartphone
7.9.3 Valant Medical Solutions Inc. Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Welligent Inc.
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Mental Health Software Product Type, Application and Specification
7.10.2.1 Desktops/ laptops
7.10.2.2 Tablets/ Smartphone
7.10.3 Welligent Inc. Mental Health Software Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=864888

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Radiotherapy Market by type, by application estimates and forecasts from 2016 – 2021

Orbis Research

Orbis Research

OrbisResearch.com offers research report on “Global Radiotherapy Market – Industry Analysis, Size, Share, Growth Trends and Forecasts (2016 – 2021)”.

TEXAS, DALLAS, USA, April 12, 2017 /EINPresswire.com/ — The global Radiotherapy market in this study is composed of various revenue generating market segments. The market is segmented into, market by various types of therapies such as External beam radiation therapy which is further sub-segmented into Intensity-modulated radiation therapy ( IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic body radiation therapy, stereotactic radiosurgery and Proton therapy. Other types of therapy are internal radiation therapy and systemic radiation therapy.

The market is also segmented into various applications of these therapies; applications such as Skin and Lip Cancer, Head and Neck Cancer, Breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer and other types of cancers.

Further, the market is segmented into types of equipment used in radiation therapy such as Liner Accelerators, Radiation therapy simulators and treatment planning systems. Lastly, the market is geographical segmented into regions of North America, Europe, Asia Pacific and rest of the world. The countries covered in North American region are USA, Canada and Mexico. Countries in Europe are France, UK, Germany, Spain and Portugal, Russia, Italy and rest of Europe. Countries in Asia Pacific are India, China, Japan, South Korea and rest of APAC countries.

Request a sample of Market Research Report @ http://www.orbisresearch.com/contacts/request-sample/255848

As companies are mediators in any market, the report encompasses of company profiles of companies such as GE Healthcare, Siemens, Toshiba, IBA, Varian, Cardinal Health, Nordion Ion Beam Applications SA, Isoray Medical Inc., Mevian Medical System, Mirada Medical and Elekta AS.

Check Out Some Important Points From TOC:

1. INTRODUCTION
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecast period years
1.6 General Study Assumptions

2. RESEARCH METHODOLOGY
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric forecast models
2.4 Research Assumptions

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Market Drivers
5.1.1 Increase in the number of cancer patients
5.1.2 Reduction in the cost of treatment
5.1.3 Lucrative reimbursement plans
5.1.4 Huge government & non-government investments in R&D of cancer treatment
5.2 Market Restraints
5.2.1 Lack of skilled personnel to perform radiotherapy
5.2.2 Inadequate Capital Investment
5.3 Market Opportunities
5.3.1 Technological innovations
5.3.2 Rise in healthcare expenditure and global GDP

6. PORTER’S FIVE FORCES ANALYSIS
6.1 Bargaining Power of suppliers
6.2 Bargaining power of buyers
6.3 Degree of competition
6.4 Threat of substitution
6.5 Threat of new entrants

Purchase Radiotherapy Market Report@ http://www.orbisresearch.com/contact/purchase/255848 and for any Queries in Buying Report please contact here@ http://www.orbisresearch.com/contacts/enquiry-before-buying/255848

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Orbis Research
+1 (214) 884-6817
email us here


Source: EIN Presswire

Global Pharmaceutical Logistics Market 2017 Size, Development Status, Type and Application,Segmentation,Forecast by 2022

Pharmaceutical Logistics Market

WiseGuyReports.com adds “Pharmaceutical Logistics Market 2017 Global Analysis, Growth,Opportunities Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, April 12, 2017 /EINPresswire.com/ — Pharmaceutical Logistics Market:

Executive Summary

This report studies the global Pharmaceutical Logistics market, analyzes and researches the Pharmaceutical Logistics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

FedEx
Deutsche Post DHL
DB Schenker
United Parcel Service of America Inc
Air Canada Cargo
Biotec Services International
CEVA
Continental Air Cargo
Kerry Logistics
LifeConEx
Marken
Nordic Cold Storage
Sofrigam
VersaCold
World Courier Management
UTi Pharma
TNT Express
Agility and GENCO

Request Sample Report @ https://www.wiseguyreports.com/sample-request/1176050-global-pharmaceutical-logistics-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers

United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Pharmaceutical Logistics can be split into

Bio Pharma Logistics
Chemical Pharma Logistics
Specially Pharma Logistics
Other

Market segment by Application, Pharmaceutical Logistics can be split into

Ground Transportation
Shipping
Air Transport

Access Report @ https://www.wiseguyreports.com/reports/1176050-global-pharmaceutical-logistics-market-size-status-and-forecast-2022

Table of Contents

Global Pharmaceutical Logistics Market Size, Status and Forecast 2022
1 Industry Overview of Pharmaceutical Logistics
1.1 Pharmaceutical Logistics Market Overview
1.1.1 Pharmaceutical Logistics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pharmaceutical Logistics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Pharmaceutical Logistics Market by Type
1.3.1 Bio Pharma Logistics
1.3.2 Chemical Pharma Logistics
1.3.3 Specially Pharma Logistics
1.3.4 Other
1.4 Pharmaceutical Logistics Market by End Users/Application
1.4.1 Ground Transportation
1.4.2 Shipping
1.4.3 Air Transport

2 Global Pharmaceutical Logistics Competition Analysis by Players
2.1 Pharmaceutical Logistics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 FedEx
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Deutsche Post DHL
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 DB Schenker
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 United Parcel Service of America Inc
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Air Canada Cargo
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Biotec Services International
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 CEVA
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Continental Air Cargo
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Kerry Logistics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 LifeConEx
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Pharmaceutical Logistics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Marken
3.12 Nordic Cold Storage
3.13 Sofrigam
3.14 VersaCold
3.15 World Courier Management
3.16 UTi Pharma
3.17 TNT Express
3.18 Agility and GENCO

4 Global Pharmaceutical Logistics Market Size by Type and Application (2012-2017)
4.1 Global Pharmaceutical Logistics Market Size by Type (2012-2017)
4.2 Global Pharmaceutical Logistics Market Size by Application (2012-2017)
4.3 Potential Application of Pharmaceutical Logistics in Future
4.4 Top Consumer/End Users of Pharmaceutical Logistics

5 United States Pharmaceutical Logistics Development Status and Outlook
5.1 United States Pharmaceutical Logistics Market Size (2012-2017)
5.2 United States Pharmaceutical Logistics Market Size and Market Share by Players (2016 and 2017)

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1176050

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire